Nutex Health (NUTX) 10-K 2012 FY Annual report

Exhibit 31.2

CHIEF FINANCIAL OFFICER CERTIFICATION

PURSUANT TO SECTION 302

I, Elisa Luqman, certify that:

1.I have reviewed this Annual Report on Form 10-K of iGambit Inc. (the “Registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material

fact or omit to state a material fact necessary to make the statements made, in light of the

circumstances under which such statements were made, not misleading with respect to the

period covered by this report.

3.Based on my knowledge, the financial statements, and other financial information

included in this report, fairly present in all material respects the financial condition, results

of operations and cash flows of the Registrant as of, and for, the periods presented in this

report;

4.The Registrant’s other certifying officer and I are responsible for establishing and

maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-

15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange

Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

a)designed such disclosure controls and procedures, or caused such disclosure controls

and procedures to be designed under our supervision, to ensure that material

information relating to the Registrant, including its consolidated subsidiaries, is made

known to us by others within those entities, particularly during the period in which

this report is being prepared;

b)   designed such internal control over financial reporting, or caused such internal control

over financial reporting to be designed under our supervision, to provide reasonable

assurance regarding the reliability of financial reporting and the preparation of

financial statements for external purposes in accordance with generally accepted

accounting principles;

c)evaluated the effectiveness of the Registrant’s disclosure controls and procedures

presented in this report our conclusions about the effectiveness of the disclosure

controls and procedures, as of the end of the period covered by this report based on

such evaluation; and

d)   disclosed in this report any change in the Registrant’s internal control over financial

reporting that occurred during the Registrant’s most recent fiscal quarter (the

Registrant’s fourth fiscal quarter in the case of an annual report) that has materially

affected, or is reasonably likely to materially affect, the Registrant’s internal control

over financial reporting; and

5.The Registrant’s other certifying officer and I have disclosed, based on our most recent

evaluation of internal control over financial reporting, to the Registrant’s auditors and the

audit committee of Registrant’s board of directors (or persons performing the equivalent

functions):

a)all significant deficiencies and material weaknesses in the design or operation of

internal control over financial reporting which are reasonably likely to adversely

affect the Registrant’s abilityto record, process, summarize and report financial

information; and

b)   any fraud, whether or not material, that involves management or other employees who

have a significant role in the Registrant’s internal control over financial reporting.

Date: June 20, 2013

/s/ Elisa Luqman

Elisa Luqman

Chief Financial Officer

(Principal Financial Officer)